Skip to main content
OpenTrials

Clinical trial condition

Depressive Disorder, Major

Explore clinical trials studying Depressive Disorder, Major. Study availability and eligibility vary by location and protocol.

2,300 public trials 326 recruiting studies
Refine in advanced search Browse all conditions

Depressive Disorder, Major trial results

Completed

Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ

NCT02548949

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Chungbuk National University Hospital Cheongju-si, Chungcheonbuk-do, South Korea
  • Hallym University Dongtan Sacred Heart Hospital/Department of Neuropsychiatry Hwaseong-si, Gyeonggi Province, South Korea
  • Hallym University Sacred Heart Hospital Anyang-si, Gyeonggi-do, South Korea
  • Roa Neurology Clinic/Neurology Bundang-gu, Seongnam-si, Gyeonggi-do, South Korea
View all 22 locations
View Trial Details
Completed

Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)

NCT01441440

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Narumi Himawari Clinic Nagoya, Aichi-ken, Japan
  • Mizuho Clinic Nagoya, Aichi-ken, Japan
  • Nippon Medical School Chiba Hokusoh Hospital Inzai, Chiba, Japan
  • Hida Clinic Nagareyama, Chiba, Japan
View all 63 locations
View Trial Details
Completed

Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)

NCT01485887

Conditions
Depressive Disorder, Depressive Disorder, Major, Major Depressive Disorder, +2 more
Locations
  • Nippon Medical School Chiba Hokusoh Hospital Inzai, Chiba, Japan
  • Nakamoto Clinic Noda, Chiba, Japan
  • Stress Care Yoshimura Clinic Fukuoka, Japan
  • Hatakeyama Clinic Kitakyushu, Fukuoka, Japan
View all 25 locations
View Trial Details
Completed

A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.

NCT00636246

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Viljandi, Viljandi Mk., Estonia
  • Pfizer Investigational Site Pärnu, Estonia
  • Pfizer Investigational Site Tallinn, Estonia
  • Pfizer Investigational Site Tartu, Estonia
View all 17 locations
View Trial Details
Completed

A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression

NCT00644982

Conditions
Depressive Disorder, Depressive Disorder, Major, Mental Disorders, +1 more
Locations
  • Pfizer Investigational Site Cairns, Queensland, Australia
  • Pfizer Investigational Site Everton Park, Queensland, Australia
  • Pfizer Investigational Site North Cairns, Queensland, Australia
  • Pfizer Investigational Site Box Hill, Victoria, Australia
View all 14 locations
View Trial Details

Related conditions